News

Globe Newswire

Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease

Business Wire

Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space

Globe Newswire

Unum Therapeutics Inc. (UMRX) Secures U.S. Patent for ACTR Technology

Globe Newswire

Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting

WealthManagement.com

Vestwell Inks a Deal With BNY Mellon

Biospace

Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-OX40 Monoclonal Antibody IBI101

Business Wire

Turnstone Biologics Unveils Novel Vaccinia Oncolytic Viral Immunotherapy Platform

BC Extra

Chi-Med, Innovent Enter Global Cancer Partnership

PRNewswire

Innovent Announces Global Collaboration with Hutchison MediPharma to Evaluate Combination of Sintilimab and Fruquintinib in Solid Tumors

Business Wire

Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy

PRNewswire

Blue Cross Blue Shield of Massachusetts Expands Medicare Network to Include Iora Health

PRNewswire

TraceLink Achieves 55% Overall Revenue Growth for Q3 2018

PRNewswire

Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism

Flywire Introduces Payment Plan Management for UK Educational Institutions

CareStack® Partners with Callpop to Expand Patient Communication Capabilities for Dental Practices Nationwide

Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement

PRNewswire

Zeel Partners With Stride Health To Bridge Insurance Gap For Massage Therapists

Globe Newswire

Cytek Biosciences Continues Momentum by Strengthening Executive Team, Adding Board Members

Tempest Therapeutics Reports Proof of Mechanism Data for First-in-Class PPAR Alpha Antagonist

Modis Therapeutics Announces Prime Designation Granted by the European Medicines Agency to MT1621 for the Treatment of TK2 Deficiency

PRNewswire

NMPA Accepts Biosimilar New Drug Application for IBI303, a Biosimilar Candidate to Humira(R) (adalimumab)

Globe Newswire

Unum Therapeutics to Present Preclinical Data on Applications of ACTR Proprietary Technology Platform in Solid Tumors at the San Antonio Breast Cancer Symposium

Innovent Highlights Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous NSCLC

Threat Stack Announces Acquisition of Runtime Application Security Vendor, Bluefyre

B3C Newswire

Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations

PRNewswire

Maine’s Northern Light Beacon Health Partners with PatientPing to Coordinate Care for Patients Throughout the State — and Beyond

Globe Newswire

Unum Therapeutics to Present Preclinical Data on a New, Emerging Platform Technology for Solid Tumors at the SITC Annual Meeting

Business Wire

Health First Selects Kyruus Solutions to Enable Digital Patient Access Initiatives

Business Wire

Health First Selects Kyruus Solutions to Enable Digital Patient Access Initiatives

Business Wire

Compass Therapeutics Announces Preclinical Data on Lead Antibody Program and NK Cell Engager Platform to be Presented at the Society for Immunotherapy of Cancer Annual Meeting

B3C Newswire

Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option

Globe Newswire

Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases

PRNewswire

PatientPing Expands Care Coordination Offering to Help Organizations Succeed Under BPCI Advanced

Reuters

China’s Innovent Biologics Makes 5 Percent Gain in Hong Kong Debut

PRNewswire

Adagene Announces First Patient Dosed in United States and Acceptance of IND in China for ADG-106

PRNewswire

RiskRecon Recognized as One of Utah’s Emerging Elite Companies

Globe Newswire

Orchard Therapeutics Announces Pricing of Initial Public Offering

PRNewswire

Snapsheet Named to CB Insights Fintech 250 List of Fastest-growing Startups

Innovent Biologics Raises $421 Million in Hong Kong IPO

Business Wire

Innovusion Raises US $30M in Series A Round and Starts Shipping the World’s First Image-Grade LiDAR System for Autonomous Vehicles

Globe Newswire

Cytek Biosciences Debuts Advanced Flow Cytometry System that Breaks the Cost Barrier

Business Wire

Kyruus Announces Launch of ProviderMatch for Salesforce on the Salesforce AppExchange to Help Health Systems Deliver Optimal Access Experience

Gene therapy biotech Orchard Therapeutics sets terms for $200 million IPO

PRNewswire

US HealthVest is Developing a New Behavioral Hospital on Hendricks Regional Health Plainfield Campus

Devoted Health, New Medicare Advantage Business, Raises $300 Million

PRNewswire

TraceLink Announces Availability of End-to-End DSCSA Saleable Returns Verification Solution for Pharmaceutical Manufacturers and Wholesale Distributors

Globe Newswire

Flywire Makes Cross-Border Payments from India Easier

PRNewswire

PatientPing’s National Community of ACO Providers Generate More than $270 Million in Shared Savings

Business Wire

Buoy Health Named to CNBC’s 2018 Upstart 100 List Highlighting Innovation and Rapid Growth

PRNewswire

FAREVA Selects TraceLink to Comply with EU FMD Regulations

Orchard Therapeutics plans $172.5 million U.S. IPO

Globe Newswire

Carbonite CEO Mohamad Ali, CarGurus and Flywire Take Top Honors at 21st Annual Mass Technology Leadership Awards

Globe Newswire

Carbonite CEO Mohamad Ali, CarGurus and Flywire Take Top Honors at 21st Annual Mass Technology Leadership Awards

Business Wire

Buoy Health Receives Robert Wood Johnson Foundation Artificial Intelligence Award for Patient Health Education

TraceLink Surpasses 1,000 Customer Milestone, Including Over 500 Pharmaceutical Manufacturing Companies

Centogene, Denali Therapeutics Partner to Recruit Parkinson’s Patients for Drug Program

FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company

Notable Health Named an IDC Innovator for Enterprise Wearable Software Solutions in Health Care

Modis Therapeutics Announces $30M Series A Financing

Pharmeasy raises $50 million in Series C funding

Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188

Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture

NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with Previously Treated Non-Small Cell Lung Cancer at Annual Meeting of the Chinese Society of Clinical Oncology

b-ONE Ortho Receives U.S. FDA 510(k) Clearance for Total Hip System

CareStack™ Announces Completion of $16 Million Financing to Expand Cloud-Based Enterprise Platform for Dental Practices

Devoted Health Receives License from State of Florida

Hua Medicine Successfully Completes Initial Public Offering and Listing on the Hong Kong Stock Exchange

Iora Health and Humana Expand Relationship to Provide More Humana Medicare Advantage Plan Members Access to Improved Care in Arizona, Georgia and Washington

Innovent doses first patient in Phase III sintilimab trial for NSCLC

Gilead Sciences and Precision BioSciences Announce Collaboration to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing

RiskRecon and Whistic Announce Partnership

OTA Insight honoured as ‘One to Watch’ in Sunday Times Tech Track 100

Unum Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference

Innovent’s Anti-CD47 Antibody IBI188 Receives IND Approval in China

Flywire Executives Featured at Boston FinTech Week

Notable Health Closes $13.5 Million Series A Financing to Expand Artificial Intelligence Powered Physician-Patient Interaction Platform

Tempest Therapeutics Names Dr. Ginna Laport CMO

Checkmate Pharmaceuticals Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate Combination Therapy with CMP-001 and Avelumab

Precision BioSciences Announces Collaboration with University of Pennsylvania to Develop Genome Editing Therapeutics

Turnstone Biologics and the La Jolla Institute for Allergy and Immunology Enter into Strategic Collaboration for Personalized Neoantigen Immunotherapies

Surface Oncology to Present at the Baird 2018 Global Healthcare Conference

Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs

Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs

Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources

TraceLink, which helps pharma companies trace drugs through the supply chain, just raised $93 million

Axoni Announces $32 Million Series B Funding Led By Goldman Sachs and Nyca Partners

Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline

Buoy Health Partners With Boston Children’s Hospital To Improve The Way Parents Currently Assess Their Children’s Symptoms Online

Even Financial Secures $25 Million in Capital Raise